CSSi's Continued Growth and Global Patient Recruitment Expansion Brings Talented New Hires

GLEN BURNIE, Md., Sept. 25, 2014 /PRNewswire/ -- CSSi (www.CSSiEnroll.com), the leader in patient recruitment solutions for the clinical research industry, is pleased to announce the recent appointment of two new hires, adding significant value and expertise to its offerings. CSSi has named Greg Fleming as Director of Business Development and Gemma Groppi as Senior Global Project Manager. Greg will be based on the West Coast working out of CSSi's San Francisco office while Gemma will be based in its UK office in London. 

Photo - http://photos.prnewswire.com/prnh/20140924/148150
Photo - http://photos.prnewswire.com/prnh/20140924/148151

With over 15 years of experience working within the pharmaceutical and clinical services industry, Greg Fleming comes to CSSi with an extensive history of sales and project management excellence across a wide range of industries, including pharmaceuticals, medical devices, media, and advertising. Formerly, Greg worked as a Business Development Manager directing sales activities to develop clinical trial patient recruitment solutions for multiple major global pharmaceutical companies. As the new Director of Business Development at CSSi, Greg will utilize his business experience in the clinical sector to guide several areas of business development with sponsor companies and CROs.

"Greg's ability to understand our business from the perspective of our pharmaceutical and clinical customers makes him uniquely positioned to provide a clear vision and direction that best meets the needs of our clients," said Charlie Speno, Vice President of CSSi's Business Development Team. "CSSi continues to be the industry expert on assisting our clients, both U.S. and global, reach their patient enrollment goals. His ability to drive sales strategy while understanding the requirements of our customers makes him an invaluable asset and a great addition to our exceptionally talented team."

With a wide-ranging background in the pharmaceutical and health care industry spanning almost 10 years, Gemma Groppi brings her comprehensive knowledge of the international clinical trial processes to CSSi. In her new role as Senior Global Project Manager at CSSi, Gemma will utilize her technical and managerial knowledge of the full clinical trial cycle in a range of therapeutic areas. Gemma will enhance CSSi's current offerings of clinical trial support with her gained experience in FIM Phase I studies, as well as extensive experience in patient recruitment phases II-III.  Additionally, Gemma has vast experience in patient recruitment and feasibility services, having worked both on site and as a project manager for various indications, including Oncology. Based in CSSi's London office, Gemma will be responsible for the management of CSSi's global team of Local Enrollment Specialists™ (LES™) --- these highly qualified clinical research professionals are providing local support to clinical trials in Europe, the Middle East and across the globe.

"Gemma brings a wealth of expertise in the health care and pharma industry as well as critical analysis and proactive decision-making capabilities that are needed to support CSSi's continued growth in our global markets," said Chris Trizna, President of CSSi. Trizna further elaborates, "Gemma's ability to understand our business from the perspective of our pharmaceutical and clinical customers makes her uniquely positioned to provide a clear vision and direction that best meets the needs of our clients. Her knowledge of the international clinical trial process will help provide enhanced patient enrollment solutions for our investigative sites across the globe. Having been on the other side of the business, she has a unique perspective and can really speak to the challenges that investigative sites face every day whether those sites are located in Europe, Israel or the United States."

About CSSi
CSSi delivers global solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. CSSi is the only patient recruitment company with a worldwide team of Local Enrollment Specialists™ (LES™), on the ground, close to sites and able to meet your study's recruitment goals on time. Our Local Enrollment Specialists™ are certified, highly experienced study coordinators located across the globe. 

CSSi has a commitment and passion for finding life cycle solutions to bring drugs or devices to market quickly by reducing development costs and resources. Our vision is to ensure that the best possible medicines and devices reach patients as quickly as possible.​

For more information on CSSi, visit www.CSSiEnroll.com, or contact Kristina Astle via email or 443-308-5827.

Contact: Kristina Astle
CSSi
P: 443-308-5827
F: 410-553-0087
Email 
www.CSSiEnroll.com

SOURCE CSSi